Identification of plasma complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach.
about
An engineered high affinity Fbs1 carbohydrate binding protein for selective capture of N-glycans and N-glycopeptidesRecent developments in proteomic methods and disease biomarkers.A targeted proteomic strategy for the measurement of oral cancer candidate biomarkers in human saliva.Neuroblastoma models for insights into tumorigenesis and new therapies.Multiplexed MRM-based assays for the quantitation of proteins in mouse plasma and heart tissue.
P2860
Identification of plasma complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Identification of plasma compl ...... antitative proteomic approach.
@en
Identification of plasma compl ...... antitative proteomic approach.
@nl
type
label
Identification of plasma compl ...... antitative proteomic approach.
@en
Identification of plasma compl ...... antitative proteomic approach.
@nl
prefLabel
Identification of plasma compl ...... antitative proteomic approach.
@en
Identification of plasma compl ...... antitative proteomic approach.
@nl
P2093
P50
P1476
Identification of plasma compl ...... antitative proteomic approach.
@en
P2093
Alla Dolnikov
Belamy B Cheung
Daniel Carter
Eric O Sekerye
Glenn M Marshall
Maria Kavallaris
Murray D Norris
Nai-Kong Cheung
Patrick Y Kim
P356
10.1016/J.JPROT.2013.10.032
P577
2013-11-04T00:00:00Z